CSL Ltd - ESG Rating & Company Profile powered by AI
Other companies in the scoring industry group for CSL Ltd are shown below. The SDG assessment for CSL Ltd represents its transparency towards the UN SDGs. The assessment of CSL Ltd was prepared by All Street Sevva using advanced Cognitive Robots.
CSL Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 4.0, social score of 3.0 and governance score of 8.0.
5.0
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
724 | Skye Bioscience Inc | 5.1 | High |
724 | Xbrane Biopharma AB | 5.1 | High |
744 | CSL Ltd | 5.0 | High |
744 | CStone Pharmaceuticals | 5.0 | High |
744 | CASI Pharmaceuticals Inc | 5.0 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does CSL Ltd have an accelerator or VC vehicle to help deliver innovation?
Does CSL Ltd disclose current and historical energy intensity?
Does CSL Ltd report the average age of the workforce?
Does CSL Ltd reference operational or capital allocation in relation to climate change?
Does CSL Ltd disclose its ethnicity pay gap?
Does CSL Ltd disclose cybersecurity risks?
Does CSL Ltd offer flexible work?
Does CSL Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does CSL Ltd disclose the number of employees in R&D functions?
Does CSL Ltd conduct supply chain audits?
Does CSL Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does CSL Ltd conduct 360 degree staff reviews?
Does CSL Ltd disclose the individual responsible for D&I?
Does CSL Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does CSL Ltd disclose current and / or historical scope 2 emissions?
Does CSL Ltd disclose water use targets?
Does CSL Ltd have careers partnerships with academic institutions?
Did CSL Ltd have a product recall in the last two years?
Does CSL Ltd disclose incidents of discrimination?
Does CSL Ltd allow for Work Councils/Collective Agreements to be formed?
Has CSL Ltd issued a profit warning in the past 24 months?
Does CSL Ltd disclose parental leave metrics?
Does CSL Ltd disclose climate scenario or pathway analysis?
Does CSL Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does CSL Ltd disclose the pay ratio of women to men?
Does CSL Ltd support suppliers with sustainability related research and development?
Does CSL Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does CSL Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is CSL Ltd involved in embryonic stem cell research?
Does CSL Ltd disclose GHG and Air Emissions intensity?
Does CSL Ltd disclose its waste policy?
Does CSL Ltd report according to TCFD requirements?
Does CSL Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does CSL Ltd disclose energy use targets?
Does CSL Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does CSL Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for CSL Ltd
These potential risks are based on the size, segment and geographies of the company.
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.